elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24241813-6D56A952-8321-4578-8BC7-9D88FDDE0C6D
Q24241813-6D56A952-8321-4578-8BC7-9D88FDDE0C6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24241813-6D56A952-8321-4578-8BC7-9D88FDDE0C6D
Anti-angiogenic therapies for metastatic colorectal cancer
P2860
Q24241813-6D56A952-8321-4578-8BC7-9D88FDDE0C6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24241813-6D56A952-8321-4578-8BC7-9D88FDDE0C6D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5cfb78b46036b2affca9ff84f8a089d2b85224a5
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer